GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.
GridAI Technologies Corp. to Present at the Market Movers Investor Summit
GridAI Technologies Corp. announced that Corporate Advisor Jérôme Cliche will present at the Market Movers Investor Summit on May 5, 2026.
The event will take place at 4:00 PM ET at the Bank of New York in New York City, featuring fireside chats with Alex Rodriguez and Grant Cardone.
The company describes itself as an AI-native energy orchestration platform focused on optimizing distributed energy resources and power infrastructure for data centers.